Prognostic significance of tissue factor pathway inhibitor-2 in pancreatic carcinoma and its effect on tumor invasion and metastasis

Medical Oncology

Volumn 27, Issue 3, 2010, Pages 867-875

  Tang, Zhigang ^a   Geng, Guangyong ^a   Huang, Qiang ^a   Xu, Geliang ^a   Hu, Hejie ^a   Chen, Jiong ^a   Li, Jiansheng ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Invasion; Metastasis; Pancreatic carcinoma; Prognostic; TFPI 2; Tissue factor pathway inhibitor 2

Indexed keywords

ENZYME PRECURSOR; MATRIX METALLOPROTEINASE; PLACENTA PROTEIN 5;

ADULT; AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER MODEL; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KAPLAN MEIER METHOD; MALE; METASTASIS; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; ANIMALS; CARCINOMA; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; PROGNOSIS; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; YOUNG ADULT;

EID: 77956920347     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9298-5     Document Type: Article

References (30)

1. S Fazal MW Saif 2007 Supportive and palliative care of pancreatic cancer JOP 8 240 253 17356251
2. JE Niederhuber MF Brennan HR Menck 1995 The National Cancer Data Base report on pancreatic cancer Cancer 76 1671 1677 10.1002/1097-0142(19951101)76: 9<1671::AID-CNCR2820760926>3.0.CO;2-R 1:STN:280:DyaK283itlagsg%3D%3D 8635074
3. V Ellenrieder G Adler TM Gress 1999 Invasion and metastasis in pancreatic cancer Ann Oncol 10 46 50 10.1023/A:1008380501633 10436784
4. M Hirata T Sato M Tsumagari K Hashizume A Ito 2003 Discoordinate regulation of expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases-3 in bovine endometrial stromal cells on type-I collagen gel Biol Pharm Bull 26 1013 1017 10.1248/bpb.26.1013 1:CAS:528:DC%2BD3sXmsFWntro%3D 12843629
5. Y Miyagi, et al. 1996 Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis Genomics 35 267 268 10.1006/geno.1996.0353 1:CAS:528:DyaK28Xkt12qurg%3D 8661135 (Pubitemid 26236182)
6. R Bützow ML Huhtala H Bohn I Virtanen M Seppälä 1988 Purification and characterization of placental protein 5 Biochem Biophys Res Commun 150 483 490 10.1016/0006-291X(88)90546-3 3276312
7. CA Sprecher W Kisiel S Mathewes DC Foster 1994 Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor Proc Natl Acad Sci USA 91 3353 3357 10.1073/pnas.91.8.3353 1:CAS:528:DyaK2cXksFaru74%3D 8159751
8. CN Rao, et al. 1996 Extracellular matrix-associated serine protease inhibitors (M 33, 000, 31, 000 and 27, 000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2 Arch Biochem Biophys 335 82 92 10.1006/abbi.1996.0484 1:CAS:528:DyaK28XmvVOls7Y%3D 8914837 (Pubitemid 26382681)
9. CN Rao, et al. 1998 HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI Int J Cancer 76 749 756 10.1002/(SICI)1097-0215(19980529)76: 5<749::AID-IJC21>3.0.CO;2-Y 1:CAS:528:DyaK1cXjsFeqs7Y%3D 9610735 (Pubitemid 28243950)
10. H Izumi C Takahashi J Oh M Noda 2000 Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes FEBS Lett 481 31 36 10.1016/S0014-5793(00)01902-5 1:CAS:528:DC%2BD3cXmtlGru70%3D 10984610 (Pubitemid 30662372)
11. M Jin, et al. 2001 Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo Gynecol Oncol 83 325 333 10.1006/gyno.2001.6394 1:CAS:528:DC%2BD3MXnsF2quro%3D 11606093 (Pubitemid 33033075)
12. SD Konduri, et al. 2001 A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion Oncogene 20 6938 6945 10.1038/sj.onc.1204847 1:CAS:528:DC%2BD3MXot1CitLg%3D 11687973 (Pubitemid 33052183)
13. LH Sobin ID Fleming 1997 TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer Cancer 80 1803 1804 10.1002/(SICI)1097-0142(19971101)80: 9<1803::AID-CNCR16>3.0.CO;2-9 1:STN:280:DyaK1c%2FhtF2itA%3D%3D 9351551 (Pubitemid 27475940)
14. Q Meng, et al. 2001 Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes J Mol Med 78 155 165 10.1007/s001090000088
15. CJ Bruns MT Harbison H Kuniyasu I Eue IJ Fidler 1999 In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice Neoplasia 1 50 62 10.1038/sj.neo.7900005 1:CAS:528:DC%2BD3cXhtFOrs7Y%3D 10935470
16. MZ Wojtukiewicz E Sierko L Zimnoch L Kozlowski W Kisiel 2003 Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue Thromb Haemost 90 140 146 1:CAS:528:DC%2BD3sXls1Wmu7Y%3D 12876637 (Pubitemid 36873870)
17. DL Crowe CF Shuler 1999 Regulation of tumor cell invasion by extracellular matrix Histol Histopathol 14 665 671 1:CAS:528:DyaK1MXjsl2mur8%3D 10212827
18. LJ McCawley LM Matrisian 2000 Matrix metalloproteinases: multifunctional contributors to tumor progression Mol Med Today 6 149 156 10.1016/S1357-4310(00) 01686-5 1:CAS:528:DC%2BD3cXitlKrsrw%3D 10740253 (Pubitemid 30171365)
19. K Nabeshima T Inoue Y Shimao T Sameshima 2002 Matrix metalloproteinases in tumor invasion: role for cell migration Pathol Int 52 255 264 10.1046/j.1440-1827.2002.01343.x 1:CAS:528:DC%2BD38XmtFWlsrY%3D 12031080 (Pubitemid 34587810)
20. F Hubé P Reverdiau S Iochmann Y Gruel 2003 Computer model of the interaction of human TFPI-2 kunitz-type serine protease inhibitor with human plasmin Thromb Res 111 197 198 10.1016/j.thromres.2003.09.021 14678821 (Pubitemid 37532861)
21. S Siegling, et al. 2004 Genetic variation in the human TFPI-2 gene and its promoter region by denaturing high performance liquid chromatography Thromb Res 113 341 343 10.1016/j.thromres.2004.03.019 1:CAS:528:DC%2BD2cXks12qs78%3D 15183047 (Pubitemid 38737376)
22. HS Chand AE Schmidt SP Bajaj W Kisiel 2004 Structure-function analysis of the reactive site in the first kunitz-type domain of human tissue factor pathway inhibitor-2 J Biol Chem 279 17500 17507 10.1074/jbc.M400802200 1:CAS:528:DC%2BD2cXjt1Gnt7g%3D 14970225 (Pubitemid 38560513)
23. CN Rao CL Peavey YY Liu JC Lapiere DT Woodley 1995 Partial characterization of matrix-associated serine protease inhibitors from human skin cells J Invest Dermatol 104 379 383 10.1111/1523-1747.ep12665851 1:CAS:528:DyaK2MXkslGgtr0%3D 7861006
24. Y Liu, et al. 1999 Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin Arch Biochem Biophys 370 112 118 10.1006/abbi.1999.1371 1:CAS:528:DyaK1MXmtVyhtb4%3D 10496984 (Pubitemid 29476957)
25. CN Rao S Mohanam A Puppala JS Rao 1999 Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor Biochem Biophys Res Commun 255 94 98 10.1006/bbrc.1999.0153 1:CAS:528:DyaK1MXhtlOru7s%3D 10082661 (Pubitemid 29292070)
26. J Rollin, et al. 2005 Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer Br J Cancer 92 775 783 10.1038/sj.bjc.6602298 1:CAS:528:DC%2BD2MXhsFWltrk%3D 15685245 (Pubitemid 40460617)
27. N Yanamandra, et al. 2005 Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line Int J Cancer 115 998 1005 10.1002/ijc.20965 1:CAS:528:DC%2BD2MXltlWrsbs%3D 15723303 (Pubitemid 40791841)
28. S Kondraganti, et al. 2006 Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line Int J Oncol 29 25 32 1:CAS:528:DC%2BD28XntlWrsL4%3D 16773181
29. SD Konduri A Tasiou N Chandrasekar GL Nicolson JS Rao 2000 Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion Clin Exp Metastasis 18 303 308 10.1023/A:1011085820250 1:CAS:528: DC%2BD3MXlsVOrtrg%3D 11448060 (Pubitemid 32579398)
30. HS Chand, et al. 2004 The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice Blood 103 1069 1077 10.1182/blood-2003-06-1930 1:CAS:528:DC%2BD2cXhtVaks7c%3D 14525759 (Pubitemid 38129573)